Our accumulating results suggested a breast cancer signalling pathway in which JAM-A associates with AF-6 and PDZ-GEF2 to activate Rap1 and regulate β1-integrin-mediated cell migration. The gene discussed is RAPGEF6; the disease is breast cancer.